Biochemistry, Adiponectin
- PMID: 30725726
- Bookshelf ID: NBK537041
Biochemistry, Adiponectin
Excerpt
Adiponectin (also known as AdipoQ or ACRP30) is a 244 amino acid monomer adipokine with a molecular weight of approximately 26 kDa. Adiponectin is the most abundant peptide hormone secreted by white adipocytes. Since discovering adiponectin in the 1990s, it has become a widely accepted biomarker for obesity-related diseases such as metabolic syndrome, Type 2 Diabetes mellitus, and atherosclerotic cardiovascular disease (ASCVD).
Adiponectin is present at high concentrations in plasma (3–30 μg/ml), which accounts for up to 0.05% of total serum protein. Adiponectin forms a wide range of multimeric species, including low molecular weight (LMW) trimers, medium molecular weight (MMW) hexamers, and high-molecular-weight (HMW) multimers. The HMW is considered to be the most biologically active form of adiponectin. Adiponectin contains two distinct domains; the N-terminal domain is a collagen-like sequence, and the C-terminal globular domain is homologous to the globular complement factor C1q. The C-terminal globular domain of adiponectin is highly similar to the structure of tumor necrosis factor-α (TNF-alpha).
Adiponectin plays a major role in cellular processes such as energy metabolism, insulin sensitivity, and inflammation. Adiponectin elicits biological activities through interaction with the cell surface receptors AdipoR1 and AdipoR2. T-cadherin (also known as cadherin 13 and H-cadherin) is considered a non-signaling receptor for adiponectin. AdipoRs are expressed in most tissues, including immune cells such as monocytes, B cells, and NK cells. However, AdipoR1 is mainly expressed in skeletal muscle, while AdipoR2 is mostly expressed in the liver. T-cadherin is highly expressed in injured vascular endothelial and smooth muscle cells.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012 Sep;55(9):2319-26. - PubMed
-
- Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003 Oct 10;278(41):40352-63. - PubMed
-
- Yamauchi T, Iwabu M, Okada-Iwabu M, Kadowaki T. Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):15-23. - PubMed
-
- Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease. Med Mol Morphol. 2007 Sep;40(3):115-20. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous